NIH-funded research U01 cooperative agreement

Improving genomic testing in patient care across Indiana

Official title: Implementing a genomics-enabled Learning Health System across Indiana

Funded at Indiana University Indianapolis · NIH-10980962 · Data updated 2026-11-12

This study is looking to improve how doctors use genetic testing to make better treatment decisions for cancer patients and those at risk of kidney disease, so they can receive more personalized care that fits their needs.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startSeptember 23, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$658,448
NIH project number1U01HG013770-01
Project IDNIH-10980962 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include patients receiving fluoropyrimidine chemotherapy or those of African ancestry at risk for chronic kidney disease.

Less likely to help

Patients who do not receive fluoropyrimidine chemotherapy or do not have risk factors associated with APOL1 variants may not benefit from this research.

What this research studies

This research aims to enhance how genomic testing is integrated into patient care by developing strategies for effective implementation and use of genetic information in clinical settings. The project will utilize a genomics-enabled learning health system to conduct two clinical trials focused on DPYD testing for patients receiving certain cancer treatments and APOL1 testing for those at risk of chronic kidney disease. By evaluating the impact of these interventions, the research seeks to improve patient outcomes through better-informed treatment decisions and personalized care. The findings will also help share tools and resources that can be adopted by healthcare providers more broadly.

Why it matters

Potential benefit: If successful, this research could lead to safer and more effective cancer treatments and improved management of chronic kidney disease for patients.

How similar studies have gone: Previous research has shown success in implementing genomic testing in clinical practice, indicating that this approach has potential for positive outcomes.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Skaar, Todd C. — Indiana University Indianapolis
  • Study coordinator: Skaar, Todd C.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.